These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27481144)

  • 21. Conserved core substructures in the overlay of protein-ligand complexes.
    Finzel BC; Akavaram R; Ragipindi A; Van Voorst JR; Cahn M; Davis ME; Pokross ME; Sheriff S; Baldwin ET
    J Chem Inf Model; 2011 Aug; 51(8):1931-41. PubMed ID: 21736376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of drug targets by chemogenomic and metabolomic profiling in yeast.
    Wu M; Zheng M; Zhang W; Suresh S; Schlecht U; Fitch WL; Aronova S; Baumann S; Davis R; St Onge R; Dill DL; Peltz G
    Pharmacogenet Genomics; 2012 Dec; 22(12):877-86. PubMed ID: 23076370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network approaches to drug discovery.
    Chandra N; Padiadpu J
    Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational analysis of ligand relationships within target families.
    Bajorath J
    Curr Opin Chem Biol; 2008 Jun; 12(3):352-8. PubMed ID: 18312862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods.
    Cheng F; Zhou Y; Li J; Li W; Liu G; Tang Y
    Mol Biosyst; 2012 Sep; 8(9):2373-84. PubMed ID: 22751809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-target view to feature selection: identification of molecular interaction features in ligand-target space.
    Niijima S; Yabuuchi H; Okuno Y
    J Chem Inf Model; 2011 Jan; 51(1):15-24. PubMed ID: 21142044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemogenomics of allosteric binding sites in GPCRs.
    Gloriam DE
    Drug Discov Today Technol; 2013; 10(2):e307-13. PubMed ID: 24050282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-scale identification of potential drug targets based on the topological features of human protein-protein interaction network.
    Li ZC; Zhong WQ; Liu ZQ; Huang MH; Xie Y; Dai Z; Zou XY
    Anal Chim Acta; 2015 Apr; 871():18-27. PubMed ID: 25847157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting drug targets based on protein domains.
    Wang YY; Nacher JC; Zhao XM
    Mol Biosyst; 2012 Apr; 8(5):1528-34. PubMed ID: 22402667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Data Mining of Chemogenomics Data Using Bi-Modal PLS Methods and Chemical Interpretation for Molecular Design.
    Hasegawa K; Funatsu K
    Mol Inform; 2014 Dec; 33(11-12):749-56. PubMed ID: 27485421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a chemogenomics library for phenotypic screening.
    Dafniet B; Cerisier N; Boezio B; Clary A; Ducrot P; Dorval T; Gohier A; Brown D; Audouze K; Taboureau O
    J Cheminform; 2021 Nov; 13(1):91. PubMed ID: 34819133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing protein domain associations by Small-molecule ligand binding.
    Li Q; Cheng T; Wang Y; Bryant SH
    J Proteome Sci Comput Biol; 2012 Dec; 1():. PubMed ID: 23745168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compound library design for target families.
    Balakin KV; Ivanenkov YA; Savchuk NP
    Methods Mol Biol; 2009; 575():21-46. PubMed ID: 19727610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2008 Dec; 3(12):1371-6. PubMed ID: 23506102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data.
    Bender A; Mikhailov D; Glick M; Scheiber J; Davies JW; Cleaver S; Marshall S; Tallarico JA; Harrington E; Cornella-Taracido I; Jenkins JL
    J Proteome Res; 2009 May; 8(5):2575-85. PubMed ID: 19271732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of different domain-based methods in protein interaction prediction.
    Ta HX; Holm L
    Biochem Biophys Res Commun; 2009 Dec; 390(3):357-62. PubMed ID: 19800868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kernel-based data fusion improves the drug-protein interaction prediction.
    Wang YC; Zhang CH; Deng NY; Wang Y
    Comput Biol Chem; 2011 Dec; 35(6):353-62. PubMed ID: 22099632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-target interaction prediction by random walk on the heterogeneous network.
    Chen X; Liu MX; Yan GY
    Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.